Surya Narayan

Thanks for the opportunity. My first question is on the new launch, peptide products that we have talked about, biological one in the US, is it relating to the Pharma or Agri?

So if you can also talk something about the new molecules, 3 molecules that has been launched for the export market and any visibility, commercial success about those and the line of the product, anything on that you can add on that?

Okay. My next question is on the capex side. See, in fact, despite of the industry challenges and all that, our capex momentum is very steady and consistent on that front. This quarter also, i t looks like more than Rs. 250, 260- odd crore kind of a number that we are looking at. So what is driving these capex investments? And what would be the full year capex guidance that you can talk about for current year?